International Biotechnology Trust PLC Ionis Pharmaceuticals Inc Transaction History
International Biotechnology Trust PLC
- $295 Million
- Q3 2023
A detailed history of International Biotechnology Trust PLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, International Biotechnology Trust PLC holds 43,000 shares of IONS stock, worth $1.34 Million. This represents 0.66% of its overall portfolio holdings.
Number of Shares
43,000
Previous 43,000
-0.0%
Holding current value
$1.34 Million
Previous $1.76 Million
10.54%
% of portfolio
0.66%
Previous 0.55%
Shares
18 transactions
Others Institutions Holding IONS
# of Institutions
411Shares Held
132MCall Options Held
829KPut Options Held
789K-
Vanguard Group Inc Valley Forge, PA16.5MShares$513 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$441 Million0.31% of portfolio
-
Capital World Investors Los Angeles, CA11.5MShares$357 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$322 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.87MShares$245 Million5.48% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.42B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...